2502.HK up 32.69% pre-market to HK$0.69 on 13 Mar 2026: watch volume

Henan Jinyuan Hydrogenated Chemicals (2502.HK) rose 32.69% pre-market to HK$0.69 on 13 Mar 2026, led by a 1,738,000.00 share intraday surge. The jump put price near the day high of HK$0.79 and well above the 50-day average of HK$0.44. Traders in Hong Kong’s HKSE reacted to higher-than-normal volume and short-term momentum signals. This note reviews 2502.HK stock moves, drivers, valuation and technicals, and provides Meyka AI data-driven context for investors.

Price action and market context: 2502.HK stock performance

2502.HK stock opened at HK$0.53 and printed a day high of HK$0.79 on the move. Volume reached 1,738,000.00 versus an average of 134,526.00, a relative volume of 12.92 that suggests outsized trading interest.

The market cap stands at HK$659,391,600.00, and year range is HK$0.79 high and HK$0.24 low. The one‑day gain of 32.69% follows a stronger YTD rise near 60.47%, highlighting elevated volatility in this Hong Kong-listed basic materials name.

Drivers and news flow: 2502.HK stock catalysts

Short-term drivers for 2502.HK stock appear to be intraday momentum and volume rather than a public corporate filing. The company operates hydrogenated benzene chemicals and energy distribution in China, a cyclical sector sensitive to commodity swings.

Investors should watch official announcements on the company site and HKEX for confirmations; the firm’s website is Henan Jinyuan Hydrogenated Chemicals and exchange filing updates can be found on HKEX.

Fundamentals and valuation: 2502.HK stock metrics

On fundamentals 2502.HK stock posts EPS of -0.08 and a PE of -8.62, reflecting trailing losses. The price to book ratio is 0.45, and price to sales is 0.15, indicating the market values the company below book on a per-share basis.

Key balance sheet metrics include cash per share 0.39 and debt to equity 0.38, with a current ratio of 1.28. These figures show modest leverage but negative profitability, so valuation remains sensitive to earnings recovery.

Technicals and volume signals: 2502.HK stock momentum

Technical indicators show strong short-term momentum for 2502.HK stock: RSI 74.22 (overbought) and ADX 31.02 signaling a strong trend. The 50-day moving average is HK$0.44 and price sits well above that level.

Volume indicators are extreme: on‑balance volume jumped and MFI sits at 88.63, which can precede pullbacks. Traders should weigh momentum against overbought signals for position sizing.

Meyka grade and model forecast: 2502.HK stock rating

Meyka AI rates 2502.HK with a score of 57.95 out of 100, Grade C+, Suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects monthly HK$0.37, quarterly HK$0.44 and yearly HK$0.46. Compared with the current price of HK$0.69, the one‑year projection implies an approximate downside of -33.33%. Forecasts are model-based projections and not guarantees.

Risks and outlook: 2502.HK stock considerations

Principal risks for 2502.HK stock include negative earnings, cash flow variability, and commodity price exposure in chemicals and energy. Interest coverage is negative and return metrics are currently below sector averages.

Sector context in Basic Materials shows healthier average ROE and PE versus 2502.HK; investors should treat gains as short-term and monitor corporate updates and sector cycles before increasing exposure.

Final Thoughts

2502.HK stock posted a sharp pre-market gain of 32.69% to HK$0.69 on 13 Mar 2026, driven by heavy volume and momentum signals. Fundamentals show EPS -0.08, PE -8.62, price to book 0.45, and cash per share 0.39, highlighting profitability challenges despite low relative valuation. Meyka AI rates the stock 57.95/100 (C+, HOLD) and models a one‑year price of HK$0.46, implying an estimated downside of -33.33% versus today’s price. Traders can use the current move for short-term trades, but longer-term investors should wait for confirmatory earnings or cash flow improvement. Always cross-check HKEX filings and the company site, and consider position sizing given high volatility. Meyka AI provides this data-driven market analysis but it is not financial advice; forecasts are projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.